pH-dependent inhibitory effects of angiotensin-converting enzyme inhibitors on cefroxadine uptake by rabbit small intestinal brush-border membrane vesicles and their relationship with hydrophobicity and the ratio of zwitterionic species

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 7, 1999, Pages 721-724

  Kitagawa, Shuji ^a   Takeda, Junko ^a   Sato, Shinji ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Angiotensin converting enzyme (ACE) inhibitor; Cefroxadine; Intestinal absorption; Small intestine brush border membrane vesicle

Indexed keywords

AMPHOLYTE; BENAZEPRIL; CARRIER PROTEIN; CEFRADINE; CEFROXADINE; CEPHALOSPORIN DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; QUINAPRIL; TEMOCAPRIL; TRANDOLAPRIL;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRUSH BORDER; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG UPTAKE; HYDROPHOBICITY; MEMBRANE VESICLE; MOLECULAR DYNAMICS; NONHUMAN; PARTITION COEFFICIENT; PH; PKA; PROTON TRANSPORT; RABBIT;

EID: 0032798059     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.721     Document Type: Article

References (20)

1. Okano T., Inui K.-I., Maegawa H., Takano M., Hori R., J. Biol. Chem., 261, 14130-14134 (1986).
2. Tsuji A., Terasaki T., Tamai I., Hirooka H., J. Pharmacol. Exp. Ther., 241, 594-601 (1987).
3. Sugawara M., Toda T., Iseki K., Miyazaki K., Shiroto H., Kondo Y., Uchino J.-I., J. Pharm. Pharmacol., 44, 968-972 (1992).
4. Kitagawa S., Sugaya Y., Biol. Pharm. Bull., 19, 268-273 (1996).
5. Fei Y. F., Kanai Y., Nussberger S., Ganapathy V., Leibach F. H., Romero M. F., Singh S. K., Boron W. F., Hediger M. A., Nature (London), 368, 563-566 (1994).
6. Liang R., Fei Y. J., Prasad P. D., Ramamoorthy S., Han H., Yang-Feng T. L., Hediger M. A., Ganapathy V., Leibach F. H., J. Biol. Chem., 270, 6456-6463 (1995).
7. Saito H., Okuda M., Terada T., Sasaki S., Inui K.-I., J. Pharmcol. Exp. Ther., 275, 1631-1637 (1995).
8. Tsuji A., Tamai I., Pharm. Res., 13, 963-977 (1996).
9. Friedman D. I., Amidon G. L., J. Pharm. Sci., 78, 995-998 (1989).
10. Hu M., Zheng L., Chen J., Liu L., Zhu Y., Dantzig A.H., Stratford R. E., Jr., Pharm. Res., 12, 1120-1125 (1995).
11. Kitagawa S., Takeda J., Kaseda Y., Sato S., Biol. Pharm. Bull., 20, 449-451 (1997).
12. Kessler M., Acuto O., Strelli C., Murer H., Müller M., Semenza G., Biochim. Biophys. Acta, 506, 136-154 (1978).
13. Leo A., Hansch C., Elkins D., Chem. Rev., 71, 525-616 (1971).
14. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., J. Biol. Chem., 193, 265-275 (1951).
15. Ranadive S. A., Chen A. X., Serajuddin A. T. M., Pharm. Res., 9, 1480-1486 (1992).
16. Adibi S. A., Gastroenterology, 113, 332-340 (1997).
17. Thwaites D. T., Cavet M., Hirst B. H., Simmons N. L., Br. J. Pharmacol., 114, 981-986 (1995).
18. Kim J. S., Oberle R. L., Krummel D. A., Dressman J. B., Fleisher D., J. Pharm. Sci., 83, 1350-1356 (1994).
19. Cabantchik Z. I., Knauf P. A., Rothstein A., Biochim. Biophys. Acta, 515, 239-302 (1978).
20. Yuasa H., Fleisher D., Amidon G. L., J. Pharmacol. Exp. Ther., 269, 1107-1111 (1994).